Biotechnology News

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceuticals issues, has released findings from the TreatmentTrends® Prostate Cancer (US) Q3 2012 report, in which...

October 8, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the fact that several leading brands are near the end of their patent...

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that over 60 percent of surveyed nephrologists in the United States expect to begin...

October 8, 2012

HARTFORD, Conn.--(BUSINESS WIRE)--Aetna announced it is expanding its integrated capabilities to offer Aetna’s disability customers and members a more simplified experience.

October 8, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Instantaneous microbial detection advances quality assurance techniques for drug compounding.

October 8, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT) today provided details of a previously announced workforce reduction that will affect approximately 38% of current employees. The company further announced that it will close...

October 8, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, October 25, 2012 at 9 a.m. ET to discuss the company’s third quarter 2012 financial and...

October 8, 2012

SOUTH SAN FRANCISCO, Calif. & PALO ALTO, Calif.--(BUSINESS WIRE)--Trellis Bioscience LLC (Trellis) and Open Monoclonal Technology, Inc. (OMT) today announced a new collaboration where the companies will join forces to generate human...

October 8, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a...

October 8, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena completes Phase 2a clinical study of TRV027 in advanced heart failure. TRV027 improved hemodynamics, was well tolerated, and preserved kidney function. TRV027 will advance to a trial in ADHF.

October 8, 2012

HYDERABAD, India--(BUSINESS WIRE)--The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced expansion in the areas of activated mPEG manufacturing and in the development and manufacture of NCE...

October 8, 2012

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Revance) today announced a settlement and termination agreement for its contractual relationships with Medicis Pharmaceutical Corporation (NYSE:MRX) concerning RT001 Botulinum Toxin...

October 8, 2012

GLEN BURNIE, Md.--(BUSINESS WIRE)--NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery™. The full-service testing program is...

October 8, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB:FCSC), a biotechnology company focused on commercializing LAVIV, the first and only FDA-approved personalized cell therapy in aesthetic dermatology, and on developing innovative...

October 8, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante’s president & CEO, will present a corporate update at the 11th Annual BIO Investor Forum hosted by the...

October 8, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announced the launch of its MediGuide Technology. The MediGuide technology allows physicians to reduce the duration of radiation exposure during cardiac procedures.

October 8, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has accepted an invitation and signed a formal...

October 8, 2012

BRUSSELS--(BUSINESS WIRE)--Delphi Genetics announces a licensing agreement with a subsidiary of Merck & Co.for the use of the StabyExpress technology,which allows high yield,cost effective protein expression without antibiotics

October 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--FDA extends by five years U.S. Patent No. 6,028,071, which covers FOLOTYN® (pralatrexate injection), postponing the original July 16, 2017 expiration date until July 16, 2022.

October 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) announced today there will be two scientific poster presentations on the effects of enobosarm, a selective androgen receptor modulator (SARM), on improving physical function and quality of...

October 8, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--Digital health and emerging patient-friendly technologies the focus of Oregon Bio conference. "Bioscience Digitization and Discovery" features 45 world-renowned speakers, focus on STEM curriculum.

October 8, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics raised 2012 aggregate partner company revenue guidance to a range of $185 million to $190 million, representing an increase of 33% to 37% as compared to $139.2 million in 2011.

October 8, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of...

October 8, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics (NYSE:SFE) will host its 6th annual Investor Day 2012, which is being held at The Yale Club of New York City. WEBCAST available...

October 8, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that the Deferred Prosecution Agreement (DPA) entered into effective September 29, 2010 with the United States Attorney’s Office for the District of New...

October 8, 2012

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics expands operations with the opening of an office in Germany. The office will provide business and technical support for prospective and current customers in the region.

October 8, 2012

NOKOMIS, Fla. And SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus Biosciences and RBCC Announce NuroPro Parkinson's Diagnostic as Target for Joint Venture

October 8, 2012

OSAKA, Japan--(BUSINESS WIRE)--Kaneka Corporation on 19 September 2012 announces the launch of KANEKA KanCapA, a new Protein A Chromatography Resin for the purification of therapeutic antibodie

October 8, 2012

MALVERN, PA.--(BUSINESS WIRE)--Researchers at Progenra, Inc. announce the advanced online publication of the article “Selective Dual Inhibitors of the Cancer-related Deubiquitylating Proteases USP7 and USP47” (Weinstock, J. et al, ACS Medicinal...

October 8, 2012

LONG BEACH, Calif.--(BUSINESS WIRE)--Functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD®) doubles the response rate and improves time-to-progression and survival in patients with advanced lung cancer, according to a...

October 5, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, October 25, 2012, after market close, the Company will...

October 5, 2012

SEATTLE--(BUSINESS WIRE)--October 5, 2012–Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Tuesday, October 30, 2012, at 9:00 a.m. ET to review third quarter financial results. Access to the...

October 5, 2012

WEST CHESTER, Pa.--(BUSINESS WIRE)--A new approach to musculoskeletal care appears to be on the horizon with the recent formation of a company, SkelRegen, aiming to regenerate human bone and other skeletal tissue.

October 5, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT has received clearance for the preparation of plasma held at 1° to 6° C within 8 hours and frozen within 24 hours after phlebotomy (PF24) and plasma held at room temperature for up to 24 hours and...

October 5, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Addressing a record crowd at the University of California, Davis, industry pundit Dr. Roberta Cook told members of the Biopesticide Industry Alliance that produce marketers are entering a new age of accountability...

October 5, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--KaloBios Pharmaceuticals, Inc. today announced that it filed a Registration Statement with the Securities and Exchange Commission for a Proposed Initial Public Offering of its common stock.

October 5, 2012

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fenwal announced today it has received FDA clearance for two new indications for collection of plasma products on the Fenwal Alyx® and Amicus® systems.

October 5, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical Launches Zilver Vena, Canada’s only venous stent indicated for use in the iliofemoral veins

October 5, 2012

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn to present update on its Feline Immunodeficiency Virus (FIV) therapeutic antibody program at the 19th West Coast Retrovirus meeting in Palm Springs, California.

October 5, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its collaboration partner GlaxoSmithKline (GSK) has discontinued clinical development of GSK2251052. As previously disclosed, GSK halted the most recent...

October 5, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Tamara Joseph, Senior Vice President and General Counsel, has resigned from the organization. The company has initiated a search for Ms. Joseph’s...

October 5, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori announced three oral presentations related to its cell therapy today at the 10th annual IFATS meeting. The findings provide insights into the mechanisms-of-action for Cytori's cell therapy.

October 5, 2012

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain is pleased to announce that Michael Heffernan, President and CEO of...

October 4, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions (NYSE:EBS) announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) of the U.S. Department of Health and...

October 4, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report third quarter 2012 financial results on Thursday, October 25, 2012, before the financial markets open. Following the release of the financials, the...

October 4, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today favorable preliminary results from a Phase 1 clinical trial in healthy adults designed to assess the pharmacokinetics (PK), safety and tolerability of single...